Radiofrequency Ablation for Treatment of Leiomyomas: Review of the Manufacturer and User Facility Device Experience (MAUDE) Database.

Radiofrequency ablation (RFA) is a relatively novel, increasingly popular treatment option for leiomyomas. We studied medical device-related reports of leiomyoma RFA devices to determine whether there are emerging device-related issues. The Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database was queried from 2012 through November 2022.

Non-extirpative Treatments for Uterine Myomas: Measuring Success.

Objective: To analyze outcomes of nonextirpative treatments for uterine myomas compared with myomectomy.

Data Sources: A systematic search of the following databases from inception to January 2020 was performed: Ovid Medline, Embase, PubMed, and Cochrane Controlled Register of Trials.

Methods Of Study Selection: Two authors reviewed titles and abstracts for relevance, and full articles were obtained and evaluated for inclusion.